Search

Author/Creator Sunderland, Katherine

3. Effectiveness of first-line abiraterone versus enzalutamide among patients ≥80 years of age with metastatic castration-resistant prostate cancer: A retrospective propensity score–weighted comparative cohort study. (July 2021)

Authors:
Soleimani, Maryam; Zou, Kevin; Sunderland, Katherine; Struss, Werner; Eigl, Bernie J.; Nappi, Lucia; Kollmannsberger, Christian K.; Finch, Daygen; Noonan, Krista; Vergidis, Joanna; Zulfiqar, Muhammad; Chi, Kim N.; Khalaf, Daniel J.
Journal:
European journal of cancer
Issue:
Volume 152(2021)
Page Start:
215
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial. Issue 12 (December 2019)

Authors:
Khalaf, Daniel J; Annala, Matti; Taavitsainen, Sinja; Finch, Daygen L; Oja, Conrad; Vergidis, Joanna; Zulfiqar, Muhammad; Sunderland, Katherine; Azad, Arun A; Kollmannsberger, Christian K; Eigl, Bernhard J; Noonan, Krista; Wadhwa, Deepa; Attwell, Andrew; Keith, Bruce; Ellard, Susan L; Le, Lyly; G...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 12(2019)
Page Start:
1730
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗